Nectar Lifesciences Limited

NSEI:NECLIFE 株式レポート

時価総額:₹9.2b

このページの翻訳は実験的なもので、現在開発中です。お待ちしております

Nectar Lifesciences マネジメント

マネジメント 基準チェック /24

現在、CEO に関する十分な情報がありません。

主要情報

Amit Chadah

最高経営責任者

n/a

報酬総額

CEO給与比率n/a
CEO在任期間3.9yrs
CEOの所有権n/a
経営陣の平均在職期間2yrs
取締役会の平均在任期間4.3yrs

経営陣の近況

Recent updates

Nectar Lifesciences Limited (NSE:NECLIFE) Shares Fly 31% But Investors Aren't Buying For Growth

Aug 22
Nectar Lifesciences Limited (NSE:NECLIFE) Shares Fly 31% But Investors Aren't Buying For Growth

Here's Why Nectar Lifesciences (NSE:NECLIFE) Has A Meaningful Debt Burden

Jul 27
Here's Why Nectar Lifesciences (NSE:NECLIFE) Has A Meaningful Debt Burden

Nectar Lifesciences Limited (NSE:NECLIFE) Stock Catapults 27% Though Its Price And Business Still Lag The Industry

Feb 19
Nectar Lifesciences Limited (NSE:NECLIFE) Stock Catapults 27% Though Its Price And Business Still Lag The Industry

Does Nectar Lifesciences (NSE:NECLIFE) Have A Healthy Balance Sheet?

Dec 22
Does Nectar Lifesciences (NSE:NECLIFE) Have A Healthy Balance Sheet?

Nectar Lifesciences (NSE:NECLIFE) Has Debt But No Earnings; Should You Worry?

Jun 16
Nectar Lifesciences (NSE:NECLIFE) Has Debt But No Earnings; Should You Worry?

Nectar Lifesciences (NSE:NECLIFE) Takes On Some Risk With Its Use Of Debt

Jun 21
Nectar Lifesciences (NSE:NECLIFE) Takes On Some Risk With Its Use Of Debt

Nectar Lifesciences (NSE:NECLIFE) Takes On Some Risk With Its Use Of Debt

Jul 29
Nectar Lifesciences (NSE:NECLIFE) Takes On Some Risk With Its Use Of Debt

Is Nectar Lifesciences Limited (NSE:NECLIFE) A Risky Dividend Stock?

Feb 25
Is Nectar Lifesciences Limited (NSE:NECLIFE) A Risky Dividend Stock?

Nectar Lifesciences (NSE:NECLIFE) Has A Somewhat Strained Balance Sheet

Jan 21
Nectar Lifesciences (NSE:NECLIFE) Has A Somewhat Strained Balance Sheet

Zooming in on NSE:NECLIFE's 0.3% Dividend Yield

Nov 02
Zooming in on NSE:NECLIFE's 0.3% Dividend Yield

Does Nectar Lifesciences (NSE:NECLIFE) Have A Healthy Balance Sheet?

Sep 07
Does Nectar Lifesciences (NSE:NECLIFE) Have A Healthy Balance Sheet?

If You Had Bought Nectar Lifesciences (NSE:NECLIFE) Stock A Year Ago, You Could Pocket A 47% Gain Today

Aug 09
If You Had Bought Nectar Lifesciences (NSE:NECLIFE) Stock A Year Ago, You Could Pocket A 47% Gain Today

The Nectar Lifesciences (NSE:NECLIFE) Share Price Has Gained 47% And Shareholders Are Hoping For More

Aug 09
The Nectar Lifesciences (NSE:NECLIFE) Share Price Has Gained 47% And Shareholders Are Hoping For More

What You Can Learn From Nectar Lifesciences Limited's (NSE:NECLIFE) P/E

Jul 13
What You Can Learn From Nectar Lifesciences Limited's (NSE:NECLIFE) P/E

CEO(最高経営責任者

Amit Chadah (54 yo)

3.9yrs

在職期間

Mr. Amit Chadah serves as the Chief Executive Officer of Nectar Lifesciences Limited since October 30, 2020. He was President of Business Development until October 30, 2020. He has joined the Nectar Lifesc...


リーダーシップ・チーム

名称ポジション在職期間報酬所有権
Sanjiv Goyal
Chairman & MDno data₹22.65m44.35%
₹ 4.1b
Puneet Sud
Director of Operations & Wholetime Director2yrs₹6.46mデータなし
Amit Chadah
Chief Executive Officer3.9yrsデータなしデータなし
Sushil Kapoor
Chief Financial Officer1.8yrsデータなしデータなし
Neha Vaishnav
Company Secretary & Compliance Officer1.8yrsデータなしデータなし

2.0yrs

平均在職期間

60.5yo

平均年齢

経験豊富な経営陣: NECLIFEの経営陣は 経験豊富 であると考えられます ( 2年の平均在職年数)。


取締役

名称ポジション在職期間報酬所有権
Sanjiv Goyal
Chairman & MDno data₹22.65m44.35%
₹ 4.1b
Puneet Sud
Director of Operations & Wholetime Director2yrs₹6.46mデータなし
Ajay Swaroop
Independent Non-Executive Director14.1yrs₹100.00kデータなし
Meena Verma
Nominee Director5.6yrs₹80.00kデータなし
Rupinder Tewari
Independent & Non-Executive Director5.6yrs₹75.00kデータなし
Kuldip Bhasin
Independent & Non-Executive Director3yrs₹120.00kデータなし
Indu Kaur
Independent & Non-Executive Director2.1yrs₹120.00kデータなし

4.3yrs

平均在職期間

64yo

平均年齢

経験豊富なボード: NECLIFEの 取締役会経験豊富 であると考えられます ( 4年の平均在任期間)。